Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

DIMENHYDRINATE

DIMENHYDRINATE

Standard Dose
50MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview DIMENHYDRINATE is listed in Drugs@FDA under application 085985 (ANDA).

Marketing status: Discontinued Active ingredient DIMENHYDRINATE Form and strength TABLET;ORAL - 50MG Sponsor NEXGEN PHARMA INC Submission history Latest submission status date: 1977-12-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview DIMENHYDRINATE is listed in Drugs@FDA under application 085985 (ANDA). Marketing status: Discontinued Active ingredient DIMENHYDRINATE Form and strength TABLET;ORAL - 50MG Sponsor NEXGEN PHARMA INC Submission history Latest submission status date: 1977-12-19 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.